Stem Cell-Derived treatment tested for stroke recovery
Disease control
Recruiting now
This early-stage trial is testing the safety and initial effectiveness of an experimental treatment called NouvSoma001 for people who recently had an ischemic stroke. The treatment involves intravenous administration of tiny particles derived from human neural stem cells. The stu…
Phase: PHASE1 • Sponsor: Wei Wang • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC